Literature DB >> 15670577

Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP).

Tomoo Nakagawa1, Simon J Hocart, Michael Schumann, Jose A Tapia, Samuel A Mantey, David H Coy, Kenji Tokita, Tatsuro Katsuno, Robert T Jensen.   

Abstract

The bombesin (Bn) receptor family includes the gastrin-releasing peptide (GRPR) and neuromedin B (NMBR) receptors, Bn receptor subtype 3 (BRS-3) and Bn receptor subtype 4 (BB(4)). They share 50% homology, yet their affinities for gastrin-releasing peptide (GRP) differ. The determinants of GRP high affinity for GRPR and BB(4), and low affinity for BRS-3 are largely unknown. To address this question we made an analysis of structural homologies in Bn receptor members correlated with their affinities for GRP to develop criteria to identify amino acids important for GRP selectivity. Fourteen differences were identified and each was mutated singly in GRPR to that found in hBRS-3. Eleven mutants had a loss of GRP affinity. Furthermore, three of four amino acids in the GRPR selected used a similar approach and previously reported to be important for high affinity Bn binding, were important for GRP affinity. Some GRPR mutants containing combinations of these mutations had greater decreases in GRP affinity than any single mutation. Particularly important for GRP selectivity were K101, Q121, A198, P199, S293, R288, T297 in GRPR. These results were confirmed by making the reverse mutations in BRS-3 to make GRP gain of affinity mutants. Modeling studies demonstrated a number of the important amino acids had side-chains oriented inward and within 6A of the binding pocket. These results demonstrated this approach could identify amino acids needed for GRP affinity and complemented results from chimera/mutagenesis studies by identifying which differences in the extracellular domains of Bn receptors were important for GRP affinity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15670577     DOI: 10.1016/j.bcp.2004.11.003

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  11 in total

Review 1.  Bombesin receptor-mediated imaging and cytotoxicity: review and current status.

Authors:  Veronica Sancho; Alessia Di Florio; Terry W Moody; Robert T Jensen
Journal:  Curr Drug Deliv       Date:  2011-01       Impact factor: 2.565

2.  The molecular basis for high affinity of a universal ligand for human bombesin receptor (BnR) family members.

Authors:  Hirotsugu Uehara; Simon J Hocart; Nieves González; Samuel A Mantey; Tomoo Nakagawa; Tatsuro Katsuno; David H Coy; Robert T Jensen
Journal:  Biochem Pharmacol       Date:  2012-07-22       Impact factor: 5.858

3.  Bombesin inhibits alveolarization and promotes pulmonary fibrosis in newborn mice.

Authors:  Khalid Ashour; Lin Shan; Jong Hwan Lee; William Schlicher; Keiji Wada; Etsuko Wada; Mary E Sunday
Journal:  Am J Respir Crit Care Med       Date:  2006-04-07       Impact factor: 21.405

4.  Molecular basis for the selectivity of the mammalian bombesin peptide, neuromedin B, for its receptor.

Authors:  Nieves González; Tomoo Nakagawa; Samuel A Mantey; Veronica Sancho; Hirotsugu Uehara; Tatsuro Katsuno; Robert T Jensen
Journal:  J Pharmacol Exp Ther       Date:  2009-07-23       Impact factor: 4.030

5.  Molecular basis for high affinity and selectivity of peptide antagonist, Bantag-1, for the orphan BB3 receptor.

Authors:  Taichi Nakamura; Irene Ramos-Álvarez; Tatiana Iordanskaia; Paola Moreno; Samuel A Mantey; R T Jensen
Journal:  Biochem Pharmacol       Date:  2016-06-23       Impact factor: 5.858

6.  Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor.

Authors:  Nieves Gonzalez; Simon J Hocart; Sergio Portal-Nuñez; Samuel A Mantey; Tomoo Nakagawa; Enrique Zudaire; David H Coy; Robert T Jensen
Journal:  J Pharmacol Exp Ther       Date:  2007-11-15       Impact factor: 4.030

Review 7.  International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.

Authors:  R T Jensen; J F Battey; E R Spindel; R V Benya
Journal:  Pharmacol Rev       Date:  2007-11-30       Impact factor: 25.468

8.  Constitutively active BRS3 is a genuinely orphan GPCR in placental mammals.

Authors:  Huihao Tang; Chuanjun Shu; Haidi Chen; Xiaojing Zhang; Zhuqing Zang; Cheng Deng
Journal:  PLoS Biol       Date:  2019-03-06       Impact factor: 8.029

9.  PESIN Conjugates for Multimodal Imaging: Can Multimerization Compensate Charge Influences on Cell Binding Properties? A Case Study.

Authors:  Ralph Hübner; Alexa Paretzki; Valeska von Kiedrowski; Marco Maspero; Xia Cheng; Güllü Davarci; Diana Braun; Helen Damerow; Benedikt Judmann; Vasileios Filippou; Clelia Dallanoce; Ralf Schirrmacher; Björn Wängler; Carmen Wängler
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-02

10.  Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer.

Authors:  Thomas Franz Fassbender; Florian Schiller; Constantinos Zamboglou; Vanessa Drendel; Selina Kiefer; Cordula A Jilg; Anca-Ligia Grosu; Michael Mix
Journal:  EJNMMI Res       Date:  2020-06-12       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.